Assessment of a Contralateral Esophagus–Sparing Technique in Locally Advanced Lung Cancer Treated With High-Dose Chemoradiation-Reference-Cited by-同舟云学术

Assessment of a Contralateral Esophagus–Sparing Technique in Locally Advanced Lung Cancer Treated With High-Dose Chemoradiation

Published:2021-06-01 Issue:6 Volume:7 Page:910
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Kamran Sophia C.¹,Yeap Beow Y.²,Ulysse Christine A.²,Cronin Catherine¹,Bowes Cynthia L.¹,Durgin Brittany¹,Gainor Justin F.²,Khandekar Melin J.¹,Tansky Joanna Y.¹³,Keane Florence K.¹³,Olsen Christine C.¹³,Willers Henning¹

Affiliation:

1. Department of Radiation Oncology, Massachusetts General Hospital, Boston

2. Department of Medicine, Massachusetts General Hospital, Boston

3. Department of Radiation Oncology, Newton-Wellesley Hospital, Newton, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2778095/jamaoncology_kamran_2021_br_210005_1623352054.55646.pdf

Reference15 articles.

1. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC.;Antonia;N Engl J Med,2018

2. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.;Faivre-Finn;Lancet Oncol,2017

3. Long-term results of NRG Oncology RTOG 0617: standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer.;Bradley;J Clin Oncol,2020

4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.;Bradley;Lancet Oncol,2015

5. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial.;Chun;J Clin Oncol,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced frequency and severity of radiation esophagitis without marginal failure risk by contralateral esophagus sparing IMRT in stage III non-small cell lung cancer patients undergoing definitive concurrent chemoradiotherapy;Radiotherapy and Oncology;2024-10

2. Interim analysis of patient-reported outcome compliance and dosimetry in a phase 3 randomized clinical trial of oesophagus-sparing spinal radiotherapy;Acta Oncologica;2023-08-30

3. Locally Advanced Lung Cancer;Hematology/Oncology Clinics of North America;2023-06

4. Effect of Segmental Abutting Esophagus-Sparing Technique to Reduce Severe Esophagitis in Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Hypofractionated Thoracic Radiation and Chemotherapy;Cancers;2023-02-27

5. Treatment of Stage III Non-small Cell Lung Cancer;Respiratory Medicine;2023